Daily Archives: March 19, 2016

Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

Posted on March 19, 2016 by Frank I. Scott, Daniel B. Horton, Ronac Mamtani, Kevin Haynes, David S. Goldberg, Dale Y. Lee, James D. Lewis

Childhood obesity is increasing and is associated with adult obesity. Antibiotics have been used to promote weight gain in livestock for several decades. Antibiotics are commonly prescribed for children, but it is not clear how exposure to antibiotics … Continue reading →

Posted in News | Comments Off on Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

Posted on March 19, 2016 by Frank I. Scott, Daniel B. Horton, Ronac Mamtani, Kevin Haynes, David S. Goldberg, Dale Y. Lee, James D. Lewis

Childhood obesity is increasing and is associated with adult obesity. Antibiotics have been used to promote weight gain in livestock for several decades. Antibiotics are commonly prescribed for children, but it is not clear how exposure to antibiotics … Continue reading →

Posted in News | Comments Off on Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors

Posted on March 19, 2016 by Yoshitatsu Sei, Jianying Feng, Xilin Zhao, Joanne Forbes, Derek Tang, Kunio Nagashima, Jeffrey Hanson, Martha M. Quezado, Marybeth S. Hughes, Stephen A. Wank

Small intestinal neuroendocrine tumors (SI-NETs) are serotonin-secreting well-differentiated neuroendocrine tumors believed to originate from enterochromaffin (EC) cells. Intestinal stem cell (ISC) are believed to contribute to the formation of SI-NETs… Continue reading →

Posted in News | Comments Off on Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors

Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors

Posted on March 19, 2016 by Yoshitatsu Sei, Jianying Feng, Xilin Zhao, Joanne Forbes, Derek Tang, Kunio Nagashima, Jeffrey Hanson, Martha M. Quezado, Marybeth S. Hughes, Stephen A. Wank

Small intestinal neuroendocrine tumors (SI-NETs) are serotonin-secreting well-differentiated neuroendocrine tumors believed to originate from enterochromaffin (EC) cells. Intestinal stem cell (ISC) are believed to contribute to the formation of SI-NETs… Continue reading →

Posted in News | Comments Off on Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors

Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival

Posted on March 19, 2016 by Sonja M. Wörmann, Liang Song, Jiaoyu Ai, Kalliope N. Diakopoulos, Magdalena U. Kurkowski, Kivanc Görgülü, Dietrich Ruess, Andrew Campbell, Claudio Doglioni, Duncan Jodrell, Albrecht Neesse, Ihsan E. Demir, Angelica-Phaedra Karpathaki, Maxim Barenboim

One treatment strategy for pancreatic ductal adenocarcinoma is to modify, rather than deplete, the tumor stroma. Constitutive activation of the signal transducer and activator of transcription 3 (STAT3) is associated with progression of pancreatic and … Continue reading →

Posted in News | Comments Off on Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival

Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival

Posted on March 19, 2016 by Sonja M. Wörmann, Liang Song, Jiaoyu Ai, Kalliope N. Diakopoulos, Magdalena U. Kurkowski, Kivanc Görgülü, Dietrich Ruess, Andrew Campbell, Claudio Doglioni, Duncan Jodrell, Albrecht Neesse, Ihsan E. Demir, Angelica-Phaedra Karpathaki, Maxim Barenboim

One treatment strategy for pancreatic ductal adenocarcinoma is to modify, rather than deplete, the tumor stroma. Constitutive activation of the signal transducer and activator of transcription 3 (STAT3) is associated with progression of pancreatic and … Continue reading →

Posted in News | Comments Off on Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival